AD 8210

Drug Profile

AD 8210

Alternative Names: AD-8210

Latest Information Update: 05 Jun 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dainippon Pharmaceutical
  • Class Antiemetics; Gastrokinetics
  • Mechanism of Action Dopamine receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Nausea and vomiting

Most Recent Events

  • 05 Jun 2001 Discontinued-Preclinical for Emesis in Japan (Unknown route)
  • 13 Oct 1997 Preclinical development for Emesis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top